Leo Pharma   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Copenhagen Denmark (1908)

Organization Overview

First Clinical Trial
1994
NCT00203580
First Marketed Drug
1989
pinacidil (Pindac)
First NDA Approval
1993
calcipotriene (dovonex)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

LEO Innovation Lab | LEO LABS | LEO PHARM | LEO Pharma | LEO PHARMA AS | LEO Pharmaceutical Products LLC | LEO Pharma GmbH, Neu-Isenburg, Germany | LEO Pharma Hellas SA | LEO Pharma Limited, Korea